Technical Analysis for AMPE - Ampio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.5 4.17% 0.02
AMPE closed up 4.17 percent on Wednesday, January 16, 2019, on 33 percent of normal volume.
7 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical AMPE trend table...

Date Alert Name Type % Chg
Jan 16 Wide Bands Range Expansion 0.00%
Jan 15 Narrow Range Bar Range Contraction 4.17%
Jan 15 NR7 Range Contraction 4.17%
Jan 15 Inside Day Range Contraction 4.17%
Jan 15 Wide Bands Range Expansion 4.17%
Jan 14 Wide Bands Range Expansion 2.04%
Jan 11 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.81%
Jan 11 Inside Day Range Contraction 0.81%
Jan 11 Wide Bands Range Expansion 0.81%
Jan 10 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.63%

Older signals for AMPE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of pharmaceutical drugs and diagnostic products to identify, treat, and prevent metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction. Its products include Ampion, a non-steroidal anti-inflammatory biologic to treat inflammatory conditions and autoimmune diseases; Optina, an orally administered danazol for the treatment of diabetic macular edema; Vasaloc for the treatment of diabetic nephropathy; and Zertane, an oral drug for treating male sexual dysfunction to premature ejaculation, which is under Phase III clinical trial. The company is also developing a handheld oxidation-reduction potential diagnostic device for use at home or in healthcare facilities that will measure the oxidants/antioxidant balances in human blood and plasma; and methylphenidate derivatives for cancer, which are in pre-clinical development. Ampio Pharmaceuticals, Inc. is headquartered in Greenwood Village, Colorado.
Is AMPE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Dec 13 FDA requires additional study of Ampio Pharma's Ampion to support marketing application; shares down 11% premarket
Dec 13 Ampio Updates Regulatory Status for Ampion
Nov 26 U.S. regulatory decision approaches for Ampio Pharma's Ampion
Nov 26 Ampio Updates Regulatory and Publication status for Ampion™
Nov 8 88 Biggest Movers From Yesterday
Nov 7 3 Health Care Stocks Rallying After US Midterms
Nov 7 Ampio Updates Regulatory and Clinical Status for Ampion™
Oct 30 Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Ampio Pharmaceuticals, Inc. (AMPE) and Encourages AMPE Investors to Contact the Firm
Oct 25 Factors of Influence in 2018, Key Indicators and Opportunity within Intersect ENT, Akari Therapeutics, Ampio Pharmaceuticals, Virtusa, Umpqua, and Hamilton Lane — New Research Emphasizes Economic Growth
Oct 24 DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
See more AMPE news...
Indicators
Indicator Value
52 Week High 3.89
52 Week Low 0.351
Average Volume 1,468,449
200-Day Moving Average 1.4071
50-Day Moving Average 0.5189
20-Day Moving Average 0.448
10-Day Moving Average 0.4789
Average True Range 0.0526
ADX 22.3
+DI 20.4533
-DI 11.7128
Chandelier Exit (Long, 3 ATRs ) 0.3922
Chandelier Exit (Short, 3 ATRs ) 0.5378
Upper Bollinger Band 0.5259
Lower Bollinger Band 0.3701
Percent B (%b) 0.83
BandWidth 34.776786
MACD Line -0.0035
MACD Signal Line -0.0148
MACD Histogram 0.0113
Fundamentals Value
Market Cap 34.12 Million
Num Shares 68.2 Million
EPS -0.21
Price-to-Earnings (P/E) Ratio -2.38
Price-to-Sales 0.00
Price-to-Book 19.82
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.56
Resistance 3 (R3) 0.56 0.53 0.55
Resistance 2 (R2) 0.53 0.52 0.54 0.55
Resistance 1 (R1) 0.52 0.51 0.53 0.52 0.54
Pivot Point 0.49 0.49 0.50 0.50 0.49
Support 1 (S1) 0.48 0.48 0.49 0.48 0.46
Support 2 (S2) 0.45 0.47 0.46 0.45
Support 3 (S3) 0.44 0.45 0.45
Support 4 (S4) 0.44